We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -2.05% | 7.15 | 6.80 | 7.50 | 7.30 | 7.15 | 7.15 | 159,594 | 08:40:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.01 | 42.92M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/7/2018 07:17 | · Loss before tax for the year was £2.5m (2016/17: £3.8m loss) · Cash and cash equivalents at 30 April 2018 were £9.5m (31 October 2017: £15m) | chimers | |
02/7/2018 07:15 | MARGINS FALLING ................oh dear. | chimers | |
02/7/2018 07:13 | Dr Arnab Basu, CEO of Kromek, said: "I am very pleased to report that Kromek had another good year of delivering revenue growth and developing our customer base who continue to launch next generation products incorporating our advanced radiation detectors. We also achieved one of our key targets for the year by becoming EBITDA positive for the first time in our history. This is an important milestone towards cash flow breakeven and pre-tax profits. "Looking ahead, the momentum of the 2017/18 financial year has been sustained into the current financial year as Kromek's products continue to gain traction in all of our target markets from the increasing adoption of CZT-based technology and other products. We continue to win new customers and, together with executing on previously-won contracts, Kromek expects to deliver growth across its business segments and to report continued revenue growth for 2018/19 in line with market expectations." | susiebe | |
02/7/2018 07:13 | · Loss before tax for the year was £2.5m (2016/17: £3.8m loss) · Cash and cash equivalents at 30 April 2018 were £9.5m (31 October 2017: £15m) | chimers | |
05/6/2018 15:09 | Walbrock’s opinions on Kromek Kromek business is growing and will likely break even on EBITDA, but on EBIT you will have to wait beyond 2020. Meanwhile, development costs (capitalized expenses) have risen to £11.6m in 2017 and will rise further. The question investor should ask: “Will the company’s valuation and share price survive when cash balance starts to fall?” On that basis, I’m leaning towards that the share price will remain under pressure because of the amount of time it will make a profit. | chimers | |
31/5/2018 15:42 | Back to its usual pattern of being sold down. It's going to take something a bit more spectacular than meeting expectations or small contract wins to break it out of the range. | cthompso | |
22/5/2018 07:45 | Note the chart double bottom, certainly looking good on the technical side. | ny boy | |
22/5/2018 07:42 | Obviously investors are ignoring the noise, I am happy with progress,looking for 40-50p by year end, enjoy. The share price won’t go up in a straight line, so expect irrational noise along the recovery path. | ny boy | |
14/5/2018 08:17 | Here we go kids.....30p+ this week. | molatovkid | |
10/5/2018 21:16 | "I think a small company like Kromek is at the start of their business cycle and lots of things can go wrong, as well as things going in the direction of the company. It is important for investors to ask themselves the following questions on Kromek: – 1). What level of sales are needed to break even? 2). Margins? 3). When will it make a profit? 4). How long will the cash pile last? 5). Is there a “break out” year? (Meaning the year, its sales accelerate) 6). How much will development costs grow as an asset? Will it distort the balance sheet? 7). Will market valuation falls, if the cash position starts declining? 8). How well do you know Kromek and the market it operates in? Have you done the market research to know if Kromek will deliver the goods? 9). Are their rivals standing in the way of Kromek? These are some of the questions you as an investor should answer. By answering them, you will know where Kromek stands and whether this is a future long-term opportunity." | chimers | |
10/5/2018 21:16 | Awwww well................ Walbrock’s opinions on Kromek Kromek business is growing and will likely break even on EBITDA, but on EBIT you will have to wait beyond 2020. Meanwhile, development costs (capitalized expenses) have risen to £11.6m in 2017 and will rise further. The question investor should ask: “Will the company’s valuation and share price survive when cash balance starts to fall?” On that basis, I’m leaning towards that the share price will remain under pressure because of the amount of time it will make a profit. | chimers | |
09/5/2018 15:28 | Chimers 2 May '18 - 14:59 - 2284 of 2294 AVOID!! Ahem..... Closing price 2/5/18: 22.60p Todays Price: 26.5p Gain: 16% Summary: Draw your own conclusions. | molatovkid |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions